Diabetes drug tested to curb cocaine cravings
NCT ID NCT06252623
Summary
This study aimed to see if a diabetes medication called exenatide (Bydureon) could help people with cocaine addiction by reducing the drug's rewarding effects. The plan was to test non-treatment-seeking adults with long-term cocaine use in a controlled lab setting, where they would choose between taking cocaine or receiving money while on the medication or a placebo. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.